RecruitingNot Applicable

DIC Markers and Thrombin Generation Parameters in Patients on ECMO Support: a Pilot Study

Hong Kong50 participantsStarted 2023-05-30

Plain-language summary

To study the correlation between novel DIC markers and thrombin generation parameters with thrombotic and hemorrhagic complications of patients on ECMO support.

Who can participate

Age range80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age ≧ 18; AND * Admitted to the mixed medical-surgical intensive care units of Queen Mary Hospital or Tuen Mun Hospital in Hong Kong; AND * Require either veno-arterial (VA) or veno-venous (VV) extracorporeal membrane oxygenation (ECMO) support. Exclusion Criteria: * Patients who are on central VA-ECMO support; OR * Patients with missing clinical data; OR * Patients with pre-existing thromboembolism requiring long term anticoagulation prior to ECMO cannulation; OR * Post-operative admissions

What they're measuring

Composite of thrombotic and hemorrhagic events

Timeframe: From the start of ECMO support to the end of ECMO support (which can be variable, typically around 5 days to 1 week)

Trial details

NCT IDNCT06095518

SponsorQueen Mary Hospital, Hong Kong

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-04-07

Contact for this trial

Wincy Ng

+852-22553111 wincyngwingsze@gmail.com

View on ClinicalTrials.gov More Extracorporeal Circulation; Complications trials